Video Experimental Relacionado
Updated: Jul 1, 2026
Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
Published on: February 14, 2025
Estudio prospectivo, multicéntrico de artroplastia cervical de 2 niveles con reemplazo total de disco cervical PEEK
Hyun W Bae1, Domagoj Coric2, K Brandon Strenge3
1Foundation for Spinal Restoration, Santa Monica, California and Cedars-Sinai Spine, Los Angeles, California.
Study Design:
Prospective, nonrandomized cohort analysis.
Objective:
To evaluate 5-year outcomes of patients treated with a polyetheretherketone (PEEK)-on-ceramic cTDR device at 2 levels for radiculopathy and/or myelopathy.
Background:
Cervical total disc replacement (cTDR) has gained acceptance as a treatment for symptomatic cervical degenerative disc disease (DDD). Long-term follow-up studies are required to further assess clinical and radiographic outcomes, specifically for patients treated at two consecutive levels.
Methods:
Patients implanted with SimplifyTM Cervical Disc at 2 levels from C3-7 as part of a Food and Drug Administration investigational device exemption trial (NCT03123549) were contacted, consented, and prospectively followed from 36 to 60-months.
Results:
Of 181 patients treated, 80% (144) completed five-year follow-up. Composite clinical success was 86% at 60 months versus 88% at 24 months. At 60 months, 95% had a minimum 15-point improvement in Neck Disability Index compared to 93% at 24 months. Mean neck pain improvement at 24 months (6.1 on a 10-point numeric scale) was maintained at 60 months. Similarly, improvements in arm pain scores were also maintained from -5.7 at 24 months to -6.2 at 60 months. The cumulative five-year index level reoperation rate was 5% (1%/year) and the adjacent level reoperation rate was 2.2% (0.4%/year). Segmental range of motion was maintained at both operated segments through five years, with an average of 9.0° at superior and 8.7° at inferior levels. Bridging bone was identified in 1% of both the superior and inferior levels, with 6% superior levels only, and 6% inferior levels only.
Conclusions:
This intermediate 5-year follow-up study augments previously reported 2-year results, supporting that the Simplify cTDR is safe and effective for the treatment of 2-level symptomatic cervical DDD. Statistically significant improvements in pain and disability at two-years postoperative were maintained or improved at five-years with preservation of motion and low reoperation rates at index and adjacent levels.
